First Time Loading...

Starpharma Holdings Ltd
ASX:SPL

Watchlist Manager
Starpharma Holdings Ltd Logo
Starpharma Holdings Ltd
ASX:SPL
Watchlist
Price: 0.12 AUD Market Closed
Updated: May 5, 2024

Starpharma Holdings Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Starpharma Holdings Ltd
Revenue Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
C
CU6

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Starpharma Holdings Ltd
ASX:SPL
Revenue
AU$10.6m
CAGR 3-Years
57%
CAGR 5-Years
19%
CAGR 10-Years
19%
Mayne Pharma Group Ltd
ASX:MYX
Revenue
AU$190.3m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Revenue
AU$237.6m
CAGR 3-Years
550%
CAGR 5-Years
77%
CAGR 10-Years
47%
Botanix Pharmaceuticals Ltd
ASX:BOT
Revenue
AU$588.4k
CAGR 3-Years
56%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Revenue
AU$221.2m
CAGR 3-Years
28%
CAGR 5-Years
24%
CAGR 10-Years
13%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Revenue
AU$11.7m
CAGR 3-Years
59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Starpharma Holdings Ltd's Revenue?
Revenue
10.6m AUD

Based on the financial report for Dec 31, 2023, Starpharma Holdings Ltd's Revenue amounts to 10.6m AUD.

What is Starpharma Holdings Ltd's Revenue growth rate?
Revenue CAGR 10Y
19%

Over the last year, the Revenue growth was 131%. The average annual Revenue growth rates for Starpharma Holdings Ltd have been 57% over the past three years , 19% over the past five years , and 19% over the past ten years .